Cargando…

Necrotizing pneumonia due to Pseudomonas aeruginosa secondary to severe COVID‐19 pneumonia

Necrotizing pneumonia (NP) can occur as a secondary infection even if the clinical course of COVID‐19 pneumonia is favorable, particularly in patients on mechanical ventilation and under immunosuppression.

Detalles Bibliográficos
Autores principales:	Hirai, Jun, Mori, Nobuaki, Asai, Nobuhiro, Mikamo, Hiroshige
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Case Images
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064028/ https://www.ncbi.nlm.nih.gov/pubmed/37006846 http://dx.doi.org/10.1002/ccr3.7164

Ejemplares similares

A Case of Severe Pneumocystis Pneumonia in an HIV-Negative Patient Successfully Treated with Oral Atovaquone
por: Hirai, Jun, et al.
Publicado: (2023)

Efficacy of Bezlotoxumab Against Clostridioides difficile Infection: A Case-Series Study at a University Hospital in Japan and Literature Review
por: Mori, Nobuaki, et al.
Publicado: (2023)

Septic shock secondary to an acute necrotizing community-acquired pneumonia with bacteremia due to Pseudomonas aeruginosa
por: Riviere, P., et al.
Publicado: (2019)

Intra-Abdominal Abscess and Bacteremia Due to Stenotrophomonas maltophilia After Total Gastrectomy: A Case Report and Literature Review
por: Hirai, Jun, et al.
Publicado: (2023)

Silver-colored colonies of Staphylococcus argenteus
por: Hirai, Jun, et al.
Publicado: (2023)

Secondary organizing pneumonia following viral pneumonia caused by severe influenza B: a case report and literature reviews
por: Asai, Nobuhiro, et al.
Publicado: (2017)

474. Real-World Experience of the Comparative Effectiveness and Safety of Remdesivir and Combination Therapy (Remdesivir and Monoclonal Antibodies) in Immunosuppressed Patients with Mild to Moderate COVID-19: A Retrospective Single-center Study in a Community Setting
por: Hirai, Jun, et al.
Publicado: (2023)

Clinical Efficacy of Fidaxomicin and Oral Metronidazole for Treating Clostridioides difficile Infection and the Associated Recurrence Rate: A Retrospective Cohort Study
por: Mori, Nobuaki, et al.
Publicado: (2023)

Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
por: Kato, Hideo, et al.
Publicado: (2022)

Cavitary lesions emerged rapidly in Pseudomonas aeruginosa pneumonia
por: Kawakami, Naoki, et al.
Publicado: (2020)

A Retrospective Study to Compare the Incidence of Hyponatremia after Administration between Linezolid and Tedizolid
por: Shibata, Yuichi, et al.
Publicado: (2023)

COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review
por: Asai, Nobuhiro, et al.
Publicado: (2021)

In Vivo Pharmacodynamics of β-Lactams/Nacubactam against Carbapenem-Resistant and/or Carbapenemase-Producing Enterobacter cloacae and Klebsiella pneumoniae in Murine Pneumonia Model
por: Hagihara, Mao, et al.
Publicado: (2021)

Complicated pyelonephritis caused by Proteus alimentorum in a woman with peritoneal cancer: a case report
por: Mori, Nobuaki, et al.
Publicado: (2023)

Efficacy of Trimethoprim–Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis
por: Kato, Hideo, et al.
Publicado: (2022)

Real-World Experience of the Comparative Effectiveness and Safety of Combination Therapy with Remdesivir and Monoclonal Antibodies versus Remdesivir Alone for Patients with Mild-to-Moderate COVID-19 and Immunosuppression: A Retrospective Single-Center Study in Aichi, Japan
por: Hirai, Jun, et al.
Publicado: (2023)

A Large Gap in Patients’ Characteristics and Outcomes between the Real-World and Clinical Trial Settings in Community-Acquired Pneumonia and Healthcare-Associated Pneumonia
por: Asai, Nobuhiro, et al.
Publicado: (2022)

Necrotizing Pseudomonas aeruginosa Community-Acquired Pneumonia: A Case Report and Review of the Literature
por: Maharaj, Satish, et al.
Publicado: (2017)

Retrospective Comparison of the Effectiveness and Safety of Ceftriaxone 1 g Twice Daily versus 2 g Once Daily for Treatment of Aspiration Pneumonia
por: Kato, Hideo, et al.
Publicado: (2022)

Tradescantia pallida extract inhibits biofilm formation in Pseudomonas aeruginosa
por: Kamiya, Mariko, et al.
Publicado: (2019)

Lemierre Syndrome Due to Dialister pneumosintes: A Case Report
por: Hirai, Jun, et al.
Publicado: (2022)

Necrotizing pneumonia in intensive care unit
por: Correia, Rui Soares
Publicado: (2023)

The First Case Report of Community-Acquired Infective Endocarditis Due to Sequence Type 1223 Staphylococcus argenteus Complicated with Convexity Subarachnoid Hemorrhage
por: Hirai, Jun, et al.
Publicado: (2022)

Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia
por: Caffrey, Aisling R., et al.
Publicado: (2022)

Necrotizing pneumonia caused by methicillin‐resistant Staphylococcus aureus
por: Hiramatsu, Toshiki, et al.
Publicado: (2022)

The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy
por: Asai, Nobuhiro, et al.
Publicado: (2022)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Pseudomonas aeruginosa necrotizing bronchopneumonia
por: Kylat, Ranjit I
Publicado: (2021)

339 An International, Multicenter, Retrospective Study of Nosocomial Pneumonia due to Pseudomonas aeruginosa
por: Micek, Scott, et al.
Publicado: (2014)

Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
por: Motos, Ana, et al.
Publicado: (2023)

Pseudomonas aeruginosa ventilator-associated pneumonia management
por: Ramírez-Estrada, Sergio, et al.
Publicado: (2016)

1628. Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia
por: Caffrey, Aisling, et al.
Publicado: (2020)

Severe Hyponatremia due to Levofloxacin Treatment for Pseudomonas aeruginosa Community-Acquired Pneumonia in a Patient with Oropharyngeal Cancer
por: Mocan, Mihaela, et al.
Publicado: (2016)

Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa
por: Kaminski, Catherine, et al.
Publicado: (2011)

Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea
por: Kim, Chung-Jong, et al.
Publicado: (2022)

MEDI3902 Correlates of Protection against Severe Pseudomonas aeruginosa Pneumonia in a Rabbit Acute Pneumonia Model
por: Le, Hoan N., et al.
Publicado: (2018)

Preexisting Trichinella spiralis infection attenuates the severity of Pseudomonas aeruginosa-induced pneumonia
por: Long, Shao Rong, et al.
Publicado: (2022)

Man with severe COVID pneumonia
por: Isokawa, Shutaro, et al.
Publicado: (2020)

A Systematic Review and Meta-Analysis of Efficacy and Safety of Azithromycin Versus Moxifloxacin for the Initial Treatment of Mycoplasma genitalium Infection
por: Kato, Hideo, et al.
Publicado: (2022)

Acute necrotizing encephalopathy secondary to sepsis
por: Zhou, Chunkui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_er7rqjo4osafb8oclv7guavilt